baber/WOPTO huggingface dataset:
Patent CY-1114640-T1 (CY)
Title: Συσκευη διανομης φαρμακευτικου υλικου
Inventor: ANDERSON GREGOR JOHN M
IPC: A61M15/00
Filed: 2013-10-17
Abstract: Παρουσιάζεται μία συσκευή διανομής φαρμακευτικού υλικού (600) για χρήση με πολλαπλούς επιμήκεις φορείς φαρμακευτικού υλικού, ο καθένας από τους οποίους έχει πολλαπλές διακριτές μερίδες δόσεων φαρμακευτικού υλικού, οι οποίες φέρονται από αυτόν, όπου η συσκευή διανομής (600) έχει ένα μηχανισμό διανομής (620) για τη διανομή των διακριτών μερίδων δόσεων φαρμακευτικού υλικού, οι οποίες φέρονται από καθέναν από τους πολλαπλούς φορείς φαρμακευτικού υλικού (601). Ο μηχανισμός περιλαμβάνει ένα σταθμό υποδοχής (602) για την υποδοχή καθενός από τους πολλαπλούς φορείς φαρμακευτικού υλικού, μία διάταξη απελευθέρωσης για την απελευθέρωση μίας διακριτής μερίδας δόσης φαρμακευτικού υλικού από καθέναν από τους πολλαπλούς φορείς φαρμακευτικού υλικού με την υποδοχή τους από το σταθμό υποδοχής, μία έξοδο (624), η οποία τοποθετείται ώστε να βρίσκεται σε επικοινωνία με τις διακριτές μερίδες δόσεων φαρμακευτικού υλικού, οι οποίες μπορούν να απελευθερώνονται από την εν λόγω διάταξη απελευθέρωσης (620) και μία διάταξη κινητού δείκτη (606) για την ξεχωριστή κίνηση των διακριτών μερίδων δόσεων φαρμακευτικού υλικού καθενός από τους πολλαπλούς φορείς φαρμακευτικού υλικού (601).
Patent CY-1117437-T1 (CY)
Title: Αντισωματα αντι-μεσοθηλινης και χρησεις αυτων
Inventor: KAHNERT ANTJE
IPC: C07K16/30
Filed: 2016-04-27
Abstract: Η παρούσα εφεύρεση παρέχει ανασυνδυασμένες περιοχές πρόσδεσης αντιγόνου και αντισώματα και λειτουργικά τμήματα που περιέχουν τέτοιες περιοχές πρόσδεσης αντιγόνου που είναι ειδικές για το αγκυροβολημένο στην μεμβράνη, 4O kDa πεπτίδιο της μεσοθηλίνης, το οποίο υπερεκφράζεται σε πολλούς όγκους, όπως παγκρεατικούς και όγκους ωοθηκών, στο μεσοθηλίωμα και σε κύτταρα καρκίνου του πνεύμονα. Αυτά τα αντισώματα, συνεπώς, μπορεί να χρησιμοποιηθούν για να θεραπεύσουν αυτές και άλλες διαταραχές και καταστάσεις. Αντισώματα της εφεύρεσης μπορούν επίσης να χρησιμοποιηθούν στον διαγνωστικό τομέα, καθώς και για περαιτέρω έρευνα του ρόλου της μεσοθηλίνης στην εξέλιξη διαταραχών που σχετίζονται με καρκίνο. Η εφεύρεση παρέχει επίσης αλληλουχίες νουκλεϊκών οξέων που κωδικοποιούν τα προαναφερθέντα αντισώματα, φορείς που περιλαμβάνουν τις ίδιες, φαρμακευτικές συνθέσεις και κιτ με οδηγίες για χρήση.
Patent CY-1117579-T1 (CY)
Title: Παραγωγα φαινυλιου-γουανiδiνης
Inventor: LORENZANO MENNA PABLO
IPC: C07D239/42
Filed: 2016-04-28
Abstract: Προβλέπονται στο παρόν παράγωγα φαινυλίου-γουανιδίνης για την αναστολή της Rac1 που αποκλείουν την αλληλεπίδραση της με τους παράγοντες ανταλλαγής γουανοσίνης (GEF) που ανήκουν στην οικογένεια DBL ως παράγοντες για την αντιμετώπιση των επιθετικών ή/και ανθεκτικών όγκων, καθώς επίσης και φαρμακευτικές συνθέσεις που τα περιλαμβάνουν, η χρήση τους στη θεραπεία και διαδικασίες για την παρασκευή τους.
Patent CY-1119718-T1 (CY)
Title: Συσκευη κλιματισμου δωματιου
Inventor: SÁNCHEZ TÁVORA EUGENIO JOSÉ
IPC: F24H3/00
Filed: 2017-11-23
Abstract: Η εφεύρεση επιτρέπει, χωρίς την κατανάλωση ενέργειας, εκπομπή αρνητικών ιόντων για τον καθαρισμό του περιβάλλοντος. Επιπλέον, η εφεύρεση έχει βιοκτόνο δράση για την εξάλειψη μικροοργανισμών και βακτηρίων. Περαιτέρω, η εφεύρεση εκπέμπει υπέρυθρη ακτινοβολία για να ξηραίνει τους τοίχους, την οροφή και τα αντικείμενα εντός του δωματίου, αφαιρώντας με τον τρόπο αυτόν την υγρασία. Για τους σκοπούς αυτούς, η εφεύρεση περιλαμβάνει ένα πλαίσιο (1, 2) και ένα πρώτο σώμα (3) το οποίο εκπέμπει αρνητικά ιόντα, που περιλαμβάνει μία πρώτη πλάκα ανοδιωμένου αλουμινίου (7) και μία δεύτερη πλάκα ανοδιωμένου αλουμινίου (8), οι οποίες καλύπτονται με μία κεραμική βαφή με εμπλουτισμένους με άργυρο ζεολίθους, που επιπλέον προς την εκπομπή αρνητικών ιόντων συνιστούν μία βιοκτόνο ένωση με βάση νανοάργυρο. Οι εν λόγω πλάκες αλουμινίου (7, 8) θερμαίνονται ομοιόμορφα μέσω ενός σύρματος (6) προκειμένου να εκπέμπουν υπέρυθρη ακτινοβολία.
Patent CY-1121037-T1 (CY)
Title: Αντινοηματικα πολυνουκλεοτιδια για να διεγειρεται παραλειψη εξονιου και μεθοδοι θεραπειας δυστροφιων
Inventor: MCNALLY ELIZABETH
IPC: C12N15/113
Filed: 2018-09-03
Abstract: Παρέχονται αντινοηματικά πολυνουκλεοτίδια και χρήση αυτών σε φαρμακευτικές συνθέσεις για να διεγείρεται παράλειψη εξονίου σε στοχευόμενα εξόνια του γονιδίου γάμμα σαρκογλυκάνης, μαζί με μεθόδους αποτροπής ή θεραπείας δυστροφικών ασθενειών, όπως Ζωνιαίας Μυϊκής Δυστροφίας. Μία άποψη της αποκάλυψης παρέχει απομονωθέν αντινοηματικά πολυνουκλεοτίδιο, όπου το πολυνουκλεοτίδιο ειδικώς υβριδοποιεί προς περιοχή εξονίου στόχου ενός RNA γάμμα σαρκογλυκάνης, όπου το εξόνιο επιλέγεται από την ομάδα που αποτελείται από εξόνιο 4 (SEQ ID ΝΟ:1), εξόνιο 5 (SEQ ID NO: 2), εξόνιο 6 (SEQ ID NO: 3), εξόνιο 7 (SEQ ID NO: 4) και συνδυασμούς αυτών. Σε μερικές πραγματοποιήσεις το αντινοηματικά πολυνουκλεοτίδιο δεν μπορεί να σχηματίσει υπόστρωμα RΝάσης Η και σε περαιτέρω πραγματοποιήσεις το αντινοηματικά πολυνουκλεοτίδιο περιλαμβάνει ραχοκοκαλιά τροποποιημένου πολυνουκλεοτιδίου.
Patent CY-1125337-T1 (CY)
Title: Σφικτηρας περιτομης μιας χρησης
Inventor: SHANG JINGJING
IPC: A61B17/326
Filed: 2021-12-21
Abstract: Ένας σφικτήρας περιτομής μια χρήσης. Ο σφικτήρας περιλαμβάνει έναν εσωτερικό δακτύλιο (1) για τοποθέτηση σε ένα πέος. Ο εσωτερικός δακτύλιος (1) συνδέεται με μία ράβδο (11). Συνολικά, ο εσωτερικός δακτύλιος (1) περιλαμβάνει μια λοξή δομή που ουσιαστικά συμμορφώνεται με τη στεφανιαία αύλακα ενός πέους. Η συσκευή επίσης περιλαμβάνει έναν εξωτερικό δακτύλιο για χρήση στο σταμάτημα της ακροποσθίας κυκλοφορίας του αίματος της κατά τη διάρκεια της επέμβασης περιτομής, με το μέγεθος και το σχήμα του εξωτερικού δακτυλίου να ταιριάζει με μια εξωτερική διάμετρο του εσωτερικού δακτυλίου. Μια δομή αποκόλλησης (14) παρέχεται στη σύνδεση μεταξύ του εσωτερικού δακτυλίου και της συνδετικής ράβδου. Οι σφικτήρες που έχουν αυτή τη δομή παρέχουν άνετη λειτουργία.
Patent HR-P20120250-T1 (HR)
Inventor: PALLE VENKATA P
IPC: C07D265/28
Filed: 2012-03-19
Abstract: Spoj, naznačen time, da je to spoj: 5-Bifenil-4-il-3-hidroksi-2-[2-(4-okso-1,2,3-benzotriazin-3(4H)-il)etil] pentanoična kiselina (spoj br. 1), 2-(2-{[(Benziloksi)karbonil]amino}etil)-5-bifenil-4-il-3-hidroksipentanoična kiselina (spoj br. 11), 5-Bifenil-4-il-3-hidroksi-2-{2-[(fenilacetil)amino]etil}pentanoična kiselina (spoj br. 45), 5-Bifenil-4-il-3-hidroksi-2-[2-(1-oksoftalazin-2(1H)-il)etil] pentanoična kiselina (spoj br. 47), 5-Bifenil-4-il-3-hidroksi-2-[2-(2'-oksospiro[ciklopropan-1,3'-indol]-1'(2'H)-il)etil] pentanoična kiselina (spoj br. 49), 3-Hidroksi-2-[2-(4-okso-1,2,3-benzotriazin-3(4H)-il)etil]-5-[4'-(trifluormetil)bifenil-4-il]pentanoična kiselina (spoj br. 59), 5-(3',4'-Difluorbifenil-4-il)-3-hidroksi-2-[2-(4-okso-1,2,3-benzotriazin-3(4H)-il)etil]pentanoična kiselina (spoj br. 60), 3-Hidroksi-5-(4'-metoksibifenil-4-il)-2-[2-(4-okso-1,2,3-benzotriazin-3(4H)-il)etil]pentanoična kiselina (spoj br. 64), 5-(4'-klorbifenil-4-il)-3-hidroksi-2-[2-(4-okso-1,2,3-benzotriazin-3 (4H)-il)etil]pentanoična kiselina (spoj br. 65), 3-Hidroksi-5-[4-(6-metoksipiridin-3-il)fenil]-2-[2-(4-okso-1,2,3-benzotriazin-3(4H)-il)etil]pentanoična kiselina (spoj br. 67), 3-Hidroksi-5-(4'-metilbifenil-4-il)-2-[2-(5-metil-1,3-diokso-1,3-dihidro-2H-izoindol-2-il)etil]pentanoična kiselina (spoj br. 68), 5-(4'-klorbifenil-4-il)-3-hidroksi-2-[2-(5-metil-1,3-diokso-1,3-dihidro-2H-izoindol-2-il)etil]pentanoična kiselina (spoj br. 69), 3-Hidroksi-2-[2-(4-okso-1,2,3-benzotriazin-3(4H)-il)etil]-5-[4'-(trifluormetoksi)bifenil-4-il]pentanoična kiselina (spoj br. 70), 5-(4'-Fluorbifenil-4-il)-3-hidroksi-2-[2-(4-okso-1,2,3-benzotriazin-3(4H)-il)etil] pentanoična kiselina (spoj br. 71), 3-hidroksi-5-(4'-metilbifenil-4-il)-2-[2-(4-okso-1,2,3-benzotriazin-3(4H)-il)etil] pentanoična kiselina (spoj br. 72), 5-(4'-Cijanobifenil-4-il)-3-hidroksi-2-[2-(4-okso-1,2,3-benzotriazin-3(4H)-il)etil] pentanoična kiselina (spoj br. 73), 5-(4'-Fluorbifenil-4-il)-3-hidroksi-2-[2-(5-metil-1,3-diokso-1,3-dihidro-2H-izoindol-2-il)etil]pentanoična kiselina (spoj br. 74), 3-Hidroksi-5-[4-(6-metoksipiridin-3-il)fenil]-2-[2-(5-metil-1,3-diokso-1,3-dihidro-2H-izoindol-2-il)etil]pentanoična kiselina (spoj br. 75), 5-(4'-Etilbifenil-4-il)-3-hidroksi-2-[2-(4-okso-1,2,3-benzotriazin-3(4H)-il)etil] pentanoična kiselina (spoj br. 76), 3-Hidroksi-2-[2-(5-metil-1,3-diokso-1,3-dihidro-2H-izoindol-2-il)etil]-5-[4'-(trifluormetil)bifenil-4-il]pentanoična kiselina (spoj br. 77), 5-Bifenil-4-il-3-hidroksi-2-[2-(-okso-4-fenil-4a,8a-dihidroftalazin-2(1 H)-il)etil] pentanoična kiselina (spoj br. 84), 5-Bifenil-4-il-3-hidroksi-2-[2-(3-okso-2,3-dihidro-4H-1,4-benzoksazin-4-il)etil] pentanoična kiselina (spoj br. 85), 5-Bifenil-4-il-2-{2-[(3aR,7aS)-1,3-diokso-1,3,3a,4,7,7a-heksahidro-2H-izoindol-2-il]etil}-3-hidroksipentanoična kiselina (spoj br. 86), 5-Bifenil-4-il-2-(2-([(4-fluorfenil)sulfonil]amino)etil)-3-hidroksipentanoična kiselina (spoj br. 87), 5-Bifenil-4-il-2-(2-{[(3-fluorfenil)acetil]amino}etil)-3-hidroksipenta
Patent SI-1140168-T1 (SI)
Title: Vaccination against cancer
Inventor: ECKERT HELMUT
IPC: A61K39/00
Filed: 2000-01-12
Abstract: Use of an antibody targeted to a human cellular membrane antigen, to manufacture a medicament to prophylactically and/or therapeutically vaccinate against cancer, is new.
Patent SI-1261601-T1 (SI)
Title: Substituted indoles for modulating nfkb activity
Inventor: RITZELER OLAF
IPC: C07D401/04
Filed: 2000-10-17
Abstract: Compounds of the formula I are suitable for preparing pharmaceuticals for the prophylaxis and therapy of disorders in whose course an increased activity of NFkappaB is involved.
Patent SI-1747023-T1 (SI)
Title: Methods and compositions for reducing hcv viral genome amounts in a target cell
Inventor: SARNOW PETER
IPC: A61K48/00
Filed: 2005-05-03
Abstract: Methods and compositions for reducing viral genome amounts in a target cell are provided. In the subject methods, the activity of a miRNA is inhibited in a manner sufficient to reduce the amount of viral genome in the target cell, e.g., by introducing a miRNA inhibitory agent in the target cell. Also provided are pharmaceutical compositions, kits and systems for use in practicing the subject methods. The subject invention finds use in a variety of applications, including the treatment of subjects suffering from a viral mediated disease condition, e.g., an HCV mediated disease condition.
Patent SI-2363392-T1 (SI)
Title: Styrylpyridine derivatives and their use for binding and imaging amyloid plaques
Inventor: KUNG HANK F
IPC: A61K51/00
Filed: 2007-03-26
Abstract: This invention relates to a method of imaging amyloid deposits and to styrylpyridine compounds, and methods of making radiolabeled styrylpyridine compounds useful in imaging amyloid deposits. This invention also relates to compounds, and methods of making compounds for inhibiting the aggregation of amyloid proteins to form amyloid deposits, and a method of delivering a therapeutic agent to amyloid deposits.
Patent SI-2687758-T1 (SI)
Title: Gear assembly with lubricant extraction
Inventor: STROSS WOLFGANG
IPC: F16H57/04
Filed: 2013-06-20
Abstract: The assembly (1) has a lubrication circuit (3) for supplying a lubricant to a turbine gearbox (2) and comprising a lubricant pump (4) that is designed as an emptying pump. The pump is driven independent of an operating mode of the gearbox and conveys the lubricant to wear exposed components of the gearbox via the lubrication circuit in an operating mode of the lubrication circuit. The lubrication circuit comprises an outlet (6), where the lubricant is removable from the lubrication circuit via the outlet by the emptying pump in another operating mode of the lubrication circuit. The lubricant is transmission oil.
Patent SI-3152193-T1 (SI)
Title: Tetrahydroisoquinolinone derivatives and their use in the inhibition of the hsp70 protein
Inventor: CHATTERJEE MANIK
IPC: C07D401/00
Filed: 2014-06-03
Abstract: The present invention relates to tetrahydroisoquinolinone derivatives of formula (I), pharmaceutical compositions comprising the same and the use of these derivatives in the inhibition of the Hsp70 protein. The compounds are useful in the treatment of cancer, autoimmune diseases, rheumatoid arthritis, inflammatory bowel disease and psoriasis. In formula (I) R1, R2 and R3 are optionally substituted phenyl, pyridinyl or pyrimidinyl; R4 is hydrogen or alkyl; R5 is halogen, hydroxy, alkyl, alkoxy, haloalkyl, haloalkoxy, nitro or -NR6 R7; R6 and R7 are hydrogen or alkyl; R8 is alkyl; and m is an integer of 0 to 3.
Patent TR-200807066-T1 (TR)
Title: Fizyolojik açıdan kullanışlı nıtroksıl donorleri olarak yeni n-htdroksilsülfonamid türevleri
Inventor: TOSCANO JOHN P
IPC: C07D207/36
Filed: 2007-03-16
Abstract: Buluş, fizyolojik koşullar altında, kalp yetmezliği ve iskemi/repertuzyon yaralanmaları da dahil olmak üzere, nitroksil (HNO) veren ve nitroksil terapisine cevap  veren koşullar veya hastalıkların başlamasını ve/veya gelişmesinin önlenmesinde ve/veya tedavi edilmesinde faydalı olan N-hidroksisülfonamid türevleri ile ilgilidir. Yepyeni N-hidroksisülfonamid türevleri, fizyolojik koşullar altında kontrollü bir hızda HNO serbestlerler ve HNO serbestlenme hızı, N-hidroksisülfonamid türevleri üzerindeki ödevli grupların farklılık gösteren lokasyonu ve tabiatı yoluyla modüle edilir.
Patent DE-3586769-T2 (DE)
Inventor: JAECKER A
IPC: B01J23/08
Filed: 1985-04-15
Granted: 1993-03-04
Abstract: An improved method for converting methane to higher hydrocarbon products by contacting a gas comprising methane with a contact agent at a selected temperature, the agent comprising a reducible metal oxide, a support of oxides of silicon or alkaline earth metal, and an alkali metal.
Patent DE-3687945-T2 (DE)
Inventor: FREYNE EDDY JEAN EDGARD
IPC: C07D409/06
Filed: 1986-10-22
Granted: 1993-07-01
Abstract: Novel [[[(3-pyridinyl)methylen]amino]oxy]alkanoic acids and esters of formula whereinR is hydrogen, C<sub>1-10</sub>alkyl, trifluoromethyl, Ar or Ar(C<sub>1-10</sub>alkyl), said Ar being phenyl, naphthalenyl, both being optionally substituted, pyridinyl, pyrimidinyl, furanyl or thienyl; andR¹ is hydrogen or C<sub>1-6</sub> alkyl;the pharmaceutically acceptable acid addition salts and possible stereochemically isomeric forms thereof, which compounds are inhibitors of thromboxane biosynthesis; pharmaceutical compositions containing such compounds as an active ingredient and methods of preparing said compounds and pharmaceutical compositions.
Patent DE-3783044-T2 (DE)
Inventor: GUSTAVSSON LENNART
IPC: G21F9/00
Filed: 1987-09-17
Granted: 1993-06-24
Abstract: PCT No. PCT/SE87/00420 Sec. 371 Date Mar. 17, 1989 Sec. 102(e) Date Mar. 17, 1989 PCT Filed Sep. 17, 1987 PCT Pub. No. WO88/01901 PCT Pub. Date Mar. 24, 1988.Method for cleansing gas from solid, liquid and/or gaseous contaminants, by bubbling the gas through a liquid bath (32), and by introducing the incoming gas into a distribution means (14) and causing the gas to pass in part-streams through a multiple of inlet orifices (64) located at progressively increasing depths beneath the surface (34) of the liquid (32). With increasing inlet pressure an increasing number of inlet orifices (64) are utilized for an increasing number of part-streams. The gas flow is passed from respective inlet orifices (64) through connecting means (24, 26, 28) to outlet orifices (31) located at a considerably higher height level (h) than corresponding inlet orifices (64). The gas flow is caused to flow out through venturi nozzles (28) and/or to strike against impinger or striking surfaces (39) with a minimum pressure drop corresponding to said height differential (h). In this way full operational pressure is immediately achieved, as soon as gas is passed out through any of the inlet orifices (64), and an intense mixing of gas and liquid as well as a high cleansing efficiency are guaranteed.
Patent DE-3783122-T2 (DE)
Inventor: FEINBERG JUDITH
IPC: A61P37/00
Filed: 1987-10-21
Granted: 1993-04-22
Abstract: Patients infected with the virus which causes AIDS, HTLV-III, are administered high doses of recombinant alpha interferon which are sufficient to make the patients aviremic. The high doses can range from about 5 to 75 million International units of human recombinant interferon alfa-2, preferably alfa-2b, per day by single injection. The patients can be maintained in an aviremic state by maintaining a dosage regimen of from about 10 to 35 million International units, in single doses, from 3 to 7 days per week.
Patent DE-3873292-T2 (DE)
Inventor: MARTI SALA JAIME
IPC: B65G47/14
Filed: 1988-12-16
Granted: 1993-03-18
Abstract: The machine is designed to set upright and align bottle (2) of all different forms in preparation for filling or packing. It has a hopper (1) with sides that are either right angled or gently inclined. It also has a series of modules (20) which house the bottle carriers (5). The modules (20) are driven on a trackway (17,18), connected by flexible couplings (33) and also carry a small shelf (8) for the bottle (2) which is adjustable in height.
Patent DE-3880859-T2 (DE)
Inventor: HESSEL LASSE
IPC: A23L/
Filed: 1988-02-11
Granted: 1993-08-26
Abstract: A thin-walled, condom-like tubular protective device (1) for protection against the transfer of infectious matter during sexual intercourse is disclosed. The condom-like device has at its open end a collar-shaped outwardly extending portion (3) with means (4) for radially stretching the collar and has an inner diameter which is sufficiently large to permit movement of a penis with respect to the protective device during coitus.
Patent TR-199701392-T2 (TR)
Inventor: LEE DOSUK D
IPC: A61L27/00
Filed: 1996-05-20
Abstract: Bu bulus, standart inert amorf kalsiyum fosfat bilesiginin yüksek seviyede reaktif amorf kati maddeye dönüsmesini saglayan bir prosesten ibarettir. Bu amorf kati maddeler, diger kalsiyum fosfatlarla birlikte tepkimeye sokularak, hem biyoaktiviteyi hem de dayanikliligi temin eden zayif kristalli sentetik bir hydroxyapatite olusturulabilmektedir. Bu yeni amorf madde diger kalsiyum fosfatlarla 37  C'de veya daha düsük sicakliklarda tepkimeye sokularak, zayif kristalli hydroxyapatite içeren, kemik benzeri bir madde olusturmaktadir.
Patent DE-60000155-T2 (DE)
Inventor: FEITEL MARK A
IPC: B65H75/30
Filed: 2000-06-29
Granted: 2002-12-12
Abstract: A thermal transfer printer including a chassis having opposing side frame members. A pair of cones (84) are each rotatably mounted to one of the opposing side frame members. At least one of the cones has a convex surface with one or more teeth formed thereon. A spool (70, 78, 80) is supported between the pair of cones, wherein the cone teeth engage an end of the spool for rotatably driving the spool. The spool has an elongated body with outwardly extending crush ribs which hold labeling media (40) or ink ribbon (76) thereon.  <IMAGE> <IMAGE>   <IMAGE>   <IMAGE>
Patent DE-60001839-T2 (DE)
Inventor: LINGLET STEPHANE
IPC: B29C49/48
Filed: 2000-07-03
Granted: 2004-01-15
Abstract: A rotary machine for blowing thermoplastic containers starting with a previously injected preform, comprising several blowing stations (10) each of which can bear a double cavity mould (16), wherein each station includes a blowing unit (26) which is fixed on a mount frame element (22) and provided with two blow nozzles (24). The machine can be transposed into a single cavity configuration wherein each station bears a single cavity mould (36), and the blowing unit (26) includes a second position for being fixed on the mount frame element wherein one of the nozzels (24) is arranged to correspond with the main axis (A4) of the single moulding cavity (38) of the single cavity mound (36).
Patent DE-60009954-T2 (DE)
Inventor: TULLY WILLIAM
IPC: B01D29/66
Filed: 2000-12-18
Granted: 2005-03-31
Abstract: Spent pyrophoric reaction catalyst from a reaction mixture is removed safely, cheaply, and rapidly using a single plate pressure filter. After hydrogenation, the reaction mixture is decanted, the desired hydrogenation product is removed, and catalyst-rich material which settles at the bottom of the vessel is delivered to a single plate pressure filter fitted with a filter bag 40 of permeable material. The spent catalyst is retained in the filter bag 40 and stored under water awaiting recovery. The filter apparatus 1 comprises a container having a domed base 2 , a generally cylindrical sidewall 3 terminating in an upper rim 4 closed by a lid 5 having lifting lugs 6 . The lid 5 is fixed in pressure-tight engagement with the sidewall 3 by flange engaging screw clamps 7 and an embedded polytetrafluoroethene gasket 8 . The filter bag 40 is held in position by a band 11 and may be readily released for removal of the spent catalyst material. The bag 40 may be reused.
Patent DE-60010275-T2 (DE)
Inventor: VELDHUIZEN GERRIT
IPC: A61F2/28
Filed: 2000-07-28
Granted: 2005-05-25
Abstract: A vertebral-column device that is suitable to be received in an intervertebral space between two dorsal vertebrae, the prosthesis comprising a curved strip of biocompatible material. The width of the strip being such that after placement, the strip makes contact with the vertebrae. The strip is manufactured from a material that can undergo great deformations before permanent deformation arises. The strip is curved in a shape in which the extremities are situated apart from one another and the radius of the curved parts and the thickness of the strip are chosen in such a way that when the strip is bent out into an approximately straight strip, scarcely any permanent deformation arises. Thus, the strip which has been bent out into an approximately straight strip is capable of being introduced into an intervertebral space where the strip assumes its original curved shape.
Patent DE-60015231-T2 (DE)
Inventor: HESTER ROBERT GEORGE
IPC: H01H3/14
Filed: 2000-05-15
Granted: 2005-11-03
Abstract: A head control comprises a control plate (13) operable by a user with his head and biasing means (9, 11) for biasing the control plate to a predetermined orientation. A joystick control (19) is operably connected to the control plate (13) such that movement of the control plate by the user is communicated to the joystick control (19). <IMAGE>
Patent DE-60019800-T2 (DE)
Inventor: NEUNER P
IPC: A46B3/18
Filed: 2000-12-08
Granted: 2006-01-19
Abstract: A mascara brush is disclosed that has a twisted wire core supporting a plurality of regularly disposed radially extending short and long bristles. The tips of the long bristles define an outer envelope of the brush. The short and long bristles are interspersed such that tips of the short bristles form a layer spaced inwardly from the outer envelope. The brush can be made without regard to bristle stiffness. Because the brush can be made without regard to bristle stiffness, the short bristles can have a degree of flexibility for a given length that is equal to or greater than a degree of flexibility for a given length of the long bristles. The brush is made by first forming a brush blank. The brush blank is made by providing a plurality of bristles of substantially equal length between a pair of parallel wire segments. The wire segments are initially twisted sufficiently to secure the bristles for subsequent steps. After the initial twisting, the bristles having their original lengths define the outer envelope, or the bristles may be trimmed to define the outer envelope and finish the brush blank. The short bristles are formed from a portion of the longer bristles by cutting a series of circumferentially spaced longitudinal grooves in the outer envelope of the brush blank. The wire segments are then further twisted to displace and disperse the short bristles among the long bristles such that the tips of the short bristles define a layer spaced inwardly from the tips of the long bristles.